KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Aurora Cannabis (ACB) EBT (2017 - 2025)

Aurora Cannabis has reported EBT over the past 9 years, most recently at $14.7 million for Q4 2025.

  • Quarterly EBT fell 35.8% to $14.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $9.8 million through Dec 2025, down 18.66% year-over-year, with the annual reading at $14.2 million for FY2025, 133.21% up from the prior year.
  • EBT was $14.7 million for Q4 2025 at Aurora Cannabis, up from $4.2 million in the prior quarter.
  • Over five years, EBT peaked at $23.0 million in Q4 2024 and troughed at -$795.7 million in Q1 2022.
  • The 5-year median for EBT is -$11.1 million (2021), against an average of -$92.0 million.
  • Year-over-year, EBT plummeted 508.96% in 2022 and then surged 848.67% in 2025.
  • A 5-year view of EBT shows it stood at -$59.9 million in 2021, then grew by 23.19% to -$46.0 million in 2022, then soared by 72.66% to -$12.6 million in 2023, then surged by 282.5% to $23.0 million in 2024, then tumbled by 35.8% to $14.7 million in 2025.
  • Per Business Quant, the three most recent readings for ACB's EBT are $14.7 million (Q4 2025), $4.2 million (Q3 2025), and $333431.2 (Q2 2025).